BioTuesdays

Tag - Emma Nealon

Equillium
Markets

Cantor starts Equillium at OW, PT $14

Cantor Fitzgerald launched coverage of Equillium (NASADQ:EQ) with an “overweight” rating and $14 price target. The stock closed at $5.40 on Sept. 14. Equillium is developing itolizumab, its novel CD6 targeted monoclonal...

September 15, 2021
Harpoon Therapeutics
Markets

Cantor starts Harpoon Therapeutics at OW; PT $40

Cantor Fitzgerald initiated coverage of Harpoon Therapeutics (NASDAQ:HARP) with an “overweight” rating and $40 price target. The stock closed at $20.28 on May 27. Harpoon is an immunoncology company developing a next...

May 28, 2021
89bio
Markets

Cantor starts 89bio at OW; PT $58

Cantor Fitzgerald launched coverage of 89bio (NASDAQ:ETNB) with an “overweight” rating and $58 price target. The stock closed at $25.81 on April 20. 89bio is developing BIO89-100, its injectable FGF21 hormone analog...

April 21, 2021